News Detail
Mumbai, 17 March 2025: Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA).
The New Jersey-based Sun Pharmaceutical Industries, Inc is recalling 9......
View Details
Source : CNBC TV18
Healthcare in India
Zydus Lifesciences
Pharmaceutical industry in India
Sun Pharma
Pharmaceutical industry in China
Pharmaceutical industry in Gujarat
Aurobindo Pharma
Generic Pharmaceuticals
Government Administration Activities
vials of the drug
Nelarabine
certain cancers
vials of Nelarabine Injection
New Jersey
Morphine Sulfate
treatment of certain cancers
healthcare system
SUN PHARMACEUTICAL INDUSTRIES
INC
lot of Nelarabine Injection
United States
US FOOD AND DRUG ADMINISTRATION
US Food and Drug Administration
pharmaceutical companies supply
Zydus Pharmaceuticals (USA) Inc
violative product
Zydus Pharmaceuticals">
Related News
- MIT engineers turn skin cells directly into neurons for cell therapy (17-03-2025)
- Police bust illegal sale of expired govt drugs in Kampala, 10 arrested (17-03-2025)
- Two Smugglers arrested with 11,520 Illegal Tablets (17-03-2025)
- Huge Stock of illegal cough syrups confiscated, two arrested (17-03-2025)
- Par panel suggests single independent drug controller for AYUSH (17-03-2025)
- Rise in pediatric pneumonia cases underscores the increasing issue of antibiotic resistance (16-03-2025)
- Extended use of steroids linked to risk of glaucoma, AIIMS docs caution (16-03-2025)
- Indian pharma increasing acquisitions in US amid regulatory and market shifts (16-03-2025)
- WHO announces one batch of falsified Oxycontin 80mg identified in the WHO European Region (15-03-2025)
- Counterfeit medicine manufacturing units exist in states like UP, HP and Uttarakhand: Dinesh Gundu Rao in Assembly (15-03-2025)